Chen D R
Department of Neurology, Changhai Hospital, Second Military Medical College.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1992 Feb;12(2):71-3, 67.
This paper reports the results of a double-blind trial in 220 patients with acute cerebral infarction evidenced by CT, who were randomly divided into ligusticum chuanxiong group (134 cases) and low molecular weight dextran group (86 cases). A weighted scoring system was adopted to evaluate the neurologic function and living capability. The results showed that the total therapeutic efficacy rate in chuanxiong group and in dextran 40 group were 86.6% and 62.8% respectively. The effect of chuanxiong on the treatment of acute cerebral infarction was superior to low molecular weight dextran and the difference between the two groups was statistically significant (P less than 0.01).
本文报道了一项针对220例经CT证实为急性脑梗死患者的双盲试验结果，这些患者被随机分为川芎组（134例）和低分子右旋糖酐组（86例）。采用加权评分系统评估神经功能和生活能力。结果显示，川芎组和低分子右旋糖酐组的总治疗有效率分别为86.6%和62.8%。川芎治疗急性脑梗死的效果优于低分子右旋糖酐，两组间差异有统计学意义（P<0.01）。
